ASP3026 T1962
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
ASP3026 has been used in trials studying the treatment of Solid Tumor, B-Cell Lymphoma, Advanced Malignancies, Positive for Anaplastic Lymphoma Kinase, and Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS.
CAS nr:
1097917-15-1
Purity:
98%
Molecular Weight:
580,74
SMILES:
COc1c(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)ncn2)ccc(c1)N1CCC(CC1)N1CCN(C)CC1
Formula:
C29H40N8O3S
Pathway:
Tyrosine Kinase/Adaptors,Angiogenesis,Apoptosis
Target:
ALK,ALK,Apoptosis
